image cutout quarter-circle featuring a table of healthcare providers talking; to the right is a blue background with medical supplies and text "DACS Digest" in black with a red star trailed by two parallel red lines underneath text

Bringing DC healthcare providers the latest news, events, and resources to improve care for patients with substance use disorders and chronic pain management.

April 2025

Dear DACS Provider,


Welcome to the April edition of the DACS Digest monthly newsletter!


April marks Alcohol Awareness Month, an observance established in 1987 to raise awareness and understanding of alcohol misuse, alcohol use disorder (AUD) and alcohol-related problems. According to the National Institute on Alcohol Abuse and Alcoholism, more than 178,000 deaths each year are attributable to excessive alcohol use. With additional consequences ranging from depression to several types of cancers, AUD can be navigated with the support of healthcare professionals. Through screening, identifying treatments options and providing personalized care that meets individual needs, healthcare professionals play a pivotal role in helping patients with AUD.


By visiting www.districtdacs.org or calling 1-866-337-DACS (3227), providers can access individualized consultations and educational opportunities that expand AUD care capabilities.


Explore this newsletter and the additional resources and tools available on the DACS website for additional information about provider education and treatment resources.


Sincerely,

The DACS Team

Education

Upcoming DACS Trainings

DACS Webinar

DC Prescription Drug Monitoring Program (PDMP) Basics for Providers


Wednesday, April 23 | 12:00 p.m. – 1:00 p.m.

Register

Upcoming Trainings of Interest

National Council for Mental Wellbeing

PCSS-MAUD: Integrating Alcohol Use Disorder and Medications for Alcohol Use Disorder into Palliative Care

 

Tuesday, April 8 | 1:00 p.m. – 2:00 p.m.

Register

Central East ATTC

Prescribing Buprenorphine: Adapting to New Realities

 

Wednesday, April 9 | 10:00 a.m. – 11:30 a.m.

Register

NAADAC

Motivational Interviewing for Edible THC

 

Wednesday, April 23 | 3:00 p.m. – 4:30 p.m.

Register

Grayken Center for Addiction Training & TA

Harm Reduction: Laying the Groundwork

 

Tuesday, April 29 | 2:30 p.m. – 4:00 p.m.

Register

Latest News & Research

Tele-Buprenorphine Initiations for Opioid Use Disorder Without In-Person Relationships


A cross-sectional study of buprenorphine initiations revealed that approximately 1 in 10 of these initiations are conducted via telehealth platforms. Of this telehealth cohort, 20% had no in-person clinical visit within two years prior to or 30 days after initiation. This finding suggests a significant subset of patients are receiving buprenorphine treatment without established in-person clinical relationships and raises potential implications for the overall effectiveness of opioid use disorder (OUD) treatment delivered exclusively via telehealth.


Read more...

Naloxone Knowledge, Carrying, Purchase and Use


A recent survey study showed differences in naloxone carrying rates across U.S. adults: 10.6% of the general population reported carrying naloxone, compared to 60.5% among individuals with self-reported opioid dependence. While naloxone availability is often estimated from pharmacy sales, the study identified that most naloxone carried was not purchased. Specifically, 42.4% of those in the general sample and 22.6% of those with self-reported opioid dependence who carried naloxone had ever purchased it. This finding suggests a need for alternative monitoring methods to track naloxone obtained from community organizations, hospitals and clinics or sold over the counter. The study also assessed how perceived overdose risk, both for oneself and loved ones, influenced the likelihood of carrying naloxone.


Read more...

Different forms of stigma and rural primary care professionals' willingness to prescribe buprenorphine


This qualitative study involving interviews with rural primary care professionals (PCPs) explored the impact of stigma on buprenorphine prescribing. The research identified three distinct forms of stigma influencing PCPs' willingness to provide this life-saving medication for opioid use disorder (OUD): stigma towards patients, where PCPs expressed fear of being harmed by patients with OUDs; stigma towards providers, with concerns about clinic stigmatization upon the treatment of addiction; and stigma towards buprenorphine itself, due to worries about unintentional patient harm from the partial opioid agonist. These findings underscore the complex nature of stigma as a barrier to buprenorphine access in rural areas and suggest that implementation strategies must address these different forms of stigma to improve prescribing rates.


Read more...

Nicotine and cannabis vaping among early high school adolescents: Disparities of use across sociodemographic characteristics and associations with psychosocial factors


This survey-based study examined nicotine and cannabis vaping types (i.e., nicotine-only, cannabis-only, and dual use) among 9th and 10th grade adolescents, focusing on disparities related to sociodemographic characteristics and associations with psychosocial factors. Prevalence of vaping within the past month was observed as 89.7 % for non-use, 5.9 % for nicotine-only, 1.0 % for cannabis-only and 3.4 % for dual use. Results indicated varying rates of vaping across different sociodemographic groups. Overall, nicotine-only and dual vaping were associated with poorer substance use attitudes, increased alcohol use, mental health difficulties, aggression, and negative family and school factors. Cannabis-only vaping showed similar associations, but to a lesser extent.


Read more...

Holidays and Observances

Holidays


DACS Phone Line Will Be Closed


May 26 – Memorial Day




April Observances


Alcohol Awareness Month


National Minority Health Month



National Public Health Week

April 7 – April 13


Black Maternal Health Week

April 11 – April 17


National Osteopathic Medicine Week

April 14 – April 20


National Prescription Drug Take Back Day

April 26

Relevant Resources

DACS Fact Sheet: Adolescents and Substance Use


Opioid, Stimulant, and Substance Use Disorders in Pregnant and Postpartum Patients

A screening and resource guide for healthcare providers, patients, and caregivers in the District of Columbia, prepared by the MedStar Health National Center for Human Factors in Healthcare.


Opioid Use Disorder During and After Pregnancy

A patient resource guide on tips for a Healthy Pregnancy.


Care for the Caregiver

A guide for caregivers of pregnant and postpartum patients with opioid, stimulant, and other substance use disorders.


Pocket Guides for Safe Opioid Prescribing 

Contains a number of resources to providers, including: CDC guidelines for safe opioid prescribing, a Morphine Milligram Equivalent (MME) conversion chart, a checklist for prescribing opioids for chronic pain, medications for opioid use disorder (MOUD), and additional resources for providers and patients.


The DC Prescription Drug Monitoring Program (DC PDMP) 

The Prescription Drug Monitoring Program (PDMP) aims to improve the District’s ability to identify and reduce diversion of prescription drugs in an efficient and cost effective manner that will not impede the appropriate medical utilization of controlled substances. 


Live.Long.DC 

A coordinated multi-stakeholder approach to comprehensively address the opioid epidemic by sharing data, discussing initiatives and best practices, and identifying common approaches. The initiative is led by the DC Department of Behavioral Health with a goal of reducing opioid use, misuse, and opioid-related deaths in DC. For more information about Live.Long.DC strategies and initiatives, visit: https://livelong.dc.gov/

1-866-337-DACS (3227) | www.districtdacs.org | dacs@som.umaryland.edu

LinkedIn